Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-02-27 @ 12:48 AM
Study NCT ID:
NCT00243659
Status:
COMPLETED
Last Update Posted:
2011-06-03
First Post:
2005-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-20
First Submit QC Date:
None
Study First Post Date:
2005-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-05-29
Results First Submit QC Date:
None
Results First Post Date:
2009-07-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-02
Last Update Post Date:
2011-06-03
Last Update Post Date Type:
ESTIMATED